Sanofi sponsorship draws Aussie fine

Sanofi-Aventis has been slapped with a $25,000 fine for striking a groundbreaking but controversial sponsorship deal that was expected to funnel $500,000 a year into one of Australia's top medical research institutes to help fund its work. A watchdog committee said the deal could interfere with doctor independence. Report

Suggested Articles

Pfizer isn't giving up in biosims. This week, it unveiled launches to three Roche blockbusters, with two already on the market.

Tecentriq didn’t show benefit against simple observation at delaying cancer recurrence or death in patients with muscle-invasive urothelial cancer.

Patients with epithelioid sarcoma previously had no targeted treatment options, but that'll change with Epizyme's approval for Tazverik.